JPS4864073A - - Google Patents

Info

Publication number
JPS4864073A
JPS4864073A JP46099936A JP9993671A JPS4864073A JP S4864073 A JPS4864073 A JP S4864073A JP 46099936 A JP46099936 A JP 46099936A JP 9993671 A JP9993671 A JP 9993671A JP S4864073 A JPS4864073 A JP S4864073A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP46099936A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9211371A external-priority patent/JPS4854068A/ja
Application filed filed Critical
Priority to JP46099936A priority Critical patent/JPS4864073A/ja
Priority to GB38475A priority patent/GB1398838A/en
Priority to GB1970672A priority patent/GB1398291A/en
Priority to AR241703A priority patent/AR196490A1/es
Priority to CH636272A priority patent/CH575368A5/xx
Priority to BE782822A priority patent/BE782822A/xx
Priority to FR7215314A priority patent/FR2134673A1/fr
Priority to NL7205806A priority patent/NL7205806A/xx
Priority to ES402263A priority patent/ES402263A1/es
Priority to HUOO180A priority patent/HU168838B/hu
Priority to DE19722221301 priority patent/DE2221301A1/de
Priority to CA141,153A priority patent/CA988083A/en
Priority to DD162679A priority patent/DD99563A5/xx
Publication of JPS4864073A publication Critical patent/JPS4864073A/ja
Priority to SE7507619A priority patent/SE7507619L/xx
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
JP46099936A 1971-04-30 1971-12-10 Pending JPS4864073A (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
JP46099936A JPS4864073A (de) 1971-04-30 1971-12-10
GB38475A GB1398838A (en) 1971-04-30 1972-04-27 Prostaglandin analogues and production thereof
GB1970672A GB1398291A (en) 1971-04-30 1972-04-27 Prostaglandin analogues and production thereof
NL7205806A NL7205806A (de) 1971-04-30 1972-04-28
FR7215314A FR2134673A1 (en) 1971-04-30 1972-04-28 Novel optically active isomers of prostaglandin analoguesof natural configuration useful as hypotensive agents, diuretics,contraceptives, for treating gastric ulcer and asthma, and forinhibiting platelet aggregation
CH636272A CH575368A5 (de) 1971-04-30 1972-04-28
BE782822A BE782822A (fr) 1971-04-30 1972-04-28 Nouveaux composes analogues de prostaglandine et leur fabrication
AR241703A AR196490A1 (es) 1971-04-30 1972-04-28 Un compuesto quimico intermediario desprovisto de actividad terapeutica para la produccion de prostaglandinas
ES402263A ES402263A1 (es) 1971-04-30 1972-04-29 Un metodo para sintetizar nuevos analogos de prostaglandi- na.
HUOO180A HU168838B (de) 1971-04-30 1972-04-29
DE19722221301 DE2221301A1 (de) 1971-04-30 1972-04-29 Prostaglandin-Analoge und Verfahren zu ihrer Herstellung
CA141,153A CA988083A (en) 1971-04-30 1972-05-01 Prostaglandin analogues and production thereof
DD162679A DD99563A5 (de) 1971-04-30 1972-05-02
SE7507619A SE7507619L (sv) 1971-04-30 1975-07-02 Sett att framstella nya prostaglandiner.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2909671 1971-04-30
JP9211371A JPS4854068A (de) 1971-11-17 1971-11-17
JP46099936A JPS4864073A (de) 1971-04-30 1971-12-10

Publications (1)

Publication Number Publication Date
JPS4864073A true JPS4864073A (de) 1973-09-05

Family

ID=27286426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP46099936A Pending JPS4864073A (de) 1971-04-30 1971-12-10

Country Status (12)

Country Link
JP (1) JPS4864073A (de)
AR (1) AR196490A1 (de)
BE (1) BE782822A (de)
CA (1) CA988083A (de)
CH (1) CH575368A5 (de)
DD (1) DD99563A5 (de)
DE (1) DE2221301A1 (de)
ES (1) ES402263A1 (de)
GB (2) GB1398838A (de)
HU (1) HU168838B (de)
NL (1) NL7205806A (de)
SE (1) SE7507619L (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4949963A (de) * 1972-09-16 1974-05-15
US3962312A (en) * 1972-09-21 1976-06-08 Ono Pharmaceutical Company 9,11,15-Trihydroxy prost-5-enoic acid analogues
IL43571A (en) * 1972-11-08 1977-08-31 Pfizer Omega-pentanorprostaglandins and their preparation
JPS5720305B2 (de) * 1973-02-28 1982-04-27
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ

Also Published As

Publication number Publication date
SE7507619L (sv) 1975-07-02
NL7205806A (de) 1972-11-01
AR196490A1 (es) 1974-02-06
CA988083A (en) 1976-04-27
BE782822A (fr) 1972-08-16
GB1398291A (en) 1975-06-18
DE2221301A1 (de) 1972-11-23
DD99563A5 (de) 1973-08-12
HU168838B (de) 1976-07-28
ES402263A1 (es) 1976-01-01
GB1398838A (en) 1975-06-25
CH575368A5 (de) 1976-05-14

Similar Documents

Publication Publication Date Title
HU168838B (de)
FR2134673B1 (de)
AU2658571A (de)
AU2691671A (de)
AU3005371A (de)
AU2684071A (de)
AU2742671A (de)
AU2894671A (de)
AU2941471A (de)
AU2952271A (de)
AU2836771A (de)
AU2740271A (de)
AU2588771A (de)
AU2654071A (de)
AU2938071A (de)
AU2669471A (de)
AU2684171A (de)
AU2706571A (de)
AU3038671A (de)
AU3025871A (de)
AU2724971A (de)
AU2963771A (de)
AU2726271A (de)
AU2755871A (de)
AU2940971A (de)